Ginkgo Bioworks (NYSE:DNA) said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in the...
Ginkgo provides an update on its first quarter financial results following the divestiture of its Biosecurity business
Barchart Research What to Expect from DNA Earnings DNA Generated May 6, 2026 Current Price $10.08 Consensus Rating Moderate Sell Average Move 13.93% Ginkgo Bioworks Reports Earnings Tomorrow, But the Autonomy...
Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026
BOSTON , March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to...
Ginkgo provides an update on its fourth quarter financial results
Presentation and Q&A session scheduled for post-market on Thursday, February 26, 2026
BOSTON , Feb. 18, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo") and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection solutions, today...
BOSTON , Feb. 5, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned...
BOSTON , Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference...